The metalloproteinase inhibitor GI5402 inhibits endotoxin-induced soluble CD27 and CD16 release in healthy humans
about
Small therapeutic molecules for the treatment of inflammatory bowel diseaseAltered distribution of peripheral blood memory B cells in humans chronically infected with Trypanosoma cruziMatrix metalloproteinases inhibition promotes the polyfunctionality of human natural killer cells in therapeutic antibody-based anti-tumour immunotherapy.A place for TACE.Plasma levels of soluble CD27: a simple marker to monitor immune activation during potent antiretroviral therapy in HIV-1-infected subjects.Interaction of human immunoglobulin G with CD16 on natural killer cells: ligand clearance, FcgammaRIIIA turnover and effects of metalloproteinases on FcgammaRIIIA-mediated binding, signal transduction and killing.
P2860
The metalloproteinase inhibitor GI5402 inhibits endotoxin-induced soluble CD27 and CD16 release in healthy humans
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
The metalloproteinase inhibito ...... CD16 release in healthy humans
@en
The metalloproteinase inhibito ...... D16 release in healthy humans.
@nl
type
label
The metalloproteinase inhibito ...... CD16 release in healthy humans
@en
The metalloproteinase inhibito ...... D16 release in healthy humans.
@nl
prefLabel
The metalloproteinase inhibito ...... CD16 release in healthy humans
@en
The metalloproteinase inhibito ...... D16 release in healthy humans.
@nl
P2093
P2860
P1476
The metalloproteinase inhibito ...... CD16 release in healthy humans
@en
P2093
Dekkers PE
ten Hove T
van Deventer SJ
van der Poll T
P2860
P304
P356
10.1128/IAI.68.5.3036-3039.2000
P407
P577
2000-05-01T00:00:00Z